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Delayed  hypersensitivity (DH) 1 lesions  have  been adoptively transferred 
with immune cells from lymph nodes,  spleen peritoneal exudates,  peripheral 
blood,  and  thoracic  duct  lymph  (1-5).  Isotope  labeling showed  that  these 
cells  constituted a  very small proportion of  the  cells in the  lesion (4),  and 
indirect evidence suggested  that  the  sensitized cells were  thymus dependent 
(6). Bone marrow cells constituted the majority of the mononuclear cells in a 
DH lesion and played a supporting or passive, although essential, role (3, 7, 8). 
Experiments were conducted to evaluate the ability of the thymus to provide 
the  sensitized  cells  capable  of  initiating a  DH  response  and  to  determine 
whether the bone marrow cells have a specific immunologic function as well as 
a  suporting function. 
Materials and Methods 
Antigen.--Bovine gamma globulin was obtained from Reheis Co., Inc., Chicago, Ill. The 
immunoglobulin G (BGG) fraction was isolated by elution from diethylaminoethyl  (DEAL) 
columns with 0.01 ~ phosphate buffer. Deaggregated BGG was obtained from the upper one- 
half of the tube after centrifugation at 100,000 g for 2 hr. BGG-131I  was prepared by the 
method of McConahey and Dixon (9). 
Animals.--Adult  Lewis (Le) rats  (Simonsen Laboratories,  Gilroy, Calif.) were used as 
donors and recipients of cells. Recipients ranged from 130 to 150 g in weight. 
Induction  of Tderance.--Tolerance  was induced by injecting intravenously  10 nag of de- 
aggregated BGG. To prove unresponsiveness the animals were challenged 1 wk after injection 
with 0.5 ml of complete Freund's adjuvant (CFA) containing 1 mg tubercle bacillus (H37Ra, 
Difco Laboratories, Detroit,  Mich.) and 1 nag BGG/ml. The injections were given into the 
footpads and nuchal area. 7 days after challenge and 2 days after beginning oral potassium 
iodide the animals were given intraperitoneally 30 #g of BGG-I~II containing approximately 
1 t~Ci of 1~1I and were counted daily in a whole body gamma counter. The slope of disappear- 
ance of isotope reflected the immunologic state  of the donors. A slope similar to those ob- 
tained in nonimmune rats indicated a state of tolerance (Fig. 1). 
* This is publication number  469 from the Department of Experimental Pathology, Scripps 
Clinic and Research Foundation, La Jolla, California. The work was supported by U.S. Public 
Health Service Grant AI-07007 and Atomic Energy Commission  Contract AT(04-3)-779. 
Supported by National Institutes of Health Grant 5TO1 HD00057-10. 
1  Abbreviations used in this paper: BGG, bovine immunoglobulin G; BSS, balanced salt 
solution; CFA, complete Preund's adjuvant; CFA-BGG, CFA containing BGG; DH,  de- 
layed hypersensitivity; PBS, phosphate-buffered saline. 
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Immunization.--Le  rats  were  immunized with  CFA  containing BGG  (CFA-BGG)  as 
described above. 
Skin Testing.--Skin testing was performed with 25/zg of BGG in 0.05 ml of 0.15 M phos- 
phate-buffered saline (PBS)  injected intradermally into the shaved flank. Injection sites were 
measured for erythema and induration at 6 and 24 hr, and the skin test sites were biopsied 
at 24 hr. Biopsies were fixed in 10% formalin and stained with hematoxylin and eosin. All 
immune and tolerant donors were skin tested 3 days before sacrifice.  Donors designated as 
immune had gross lesions of greater than 14 mm at 24 hr while tolerant donors had lesions of 
less than 2 mm which on random biopsies were histologically negative. Biopsies were evaluated 
histologically by two investigators independently and were considered negative when mono- 
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FIG.  1.  Group 1 (tolerant, Q--O) rats injected i.v. with deaggregated BGG on day 14 
and  intradermally with CFA-BGG on day  7  (mean of eight  animals).  Group  2  (normal, 
(D - - - ©) rats injected intradermally with CFA on day 7 (mean of three animals). Group 3 
(immune,  E]--[~) rats injected intradermaily with CFA-BGG on day 7  (mean of nine ani- 
mals). BGG-131I given intraperitoneally on day 0. 
nuclear cell infiltrates were absent. Positive biopsies were graded on a 1  +-4+  basis, depend- 
ing on the intensity of the mononuclear cell infiltrate and the microscopic extent of the lesion. 
Cell Transfers.--Donors  were anesthetized with ether and exsanguinated by cardiac punc- 
ture 14 days after immunization or challenge. Lymph node cells were obtained by teasing the 
regional nodes apart in balanced salt solution (BSS).  The thymus was freed of parathymic 
lymph nodes and cells were recovered by pressing the organ through a wire screen in BSS. 
Bone marrow cells were obtained by flushing BSS through the femoral and tibial bones and 
dispersing the cells by repeated aspiration through a 21 gauge needle. 
All ceil suspensions were washed once with BSS, counted in a  standard hemacytometer, 
and adjusted to a  concentration of 5  X  10 s cells/ml before intravenous injection into the 
recipients. Recipients were irradiated within 12 hr of transfer with a Picker 200 kv dual beam 
source (Picker X-ray Corp., White Plains, N. Y.) which delivered 53 R/min. They received 
either 550 R, in the early experiments, or 700 R, total body, in later experiments, to insure 
that there was little or no escape from the effects of irradiation during a  15 day observation 
period. There were two major groups of recipients; one was stimulated by antigen in CFA at 
the time of transfer of cells derived from various organ sources; one was not stimulated by 
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RESULTS 
The first adoptive transfer experiments were designed to determine whether 
bone marrow played an active immunological role as a  source of initiator or 
trigger  cells or  a  passive part  in the expression of  the DH lesion. Irradiated 
recipients (550 R) were given immune or tolerant lymph node cells  2 (1  X  10  s) 
and immune or tolerant bone marrow cells (2.5 X  108) (Table I). All six animals 
receiving immune lymph node cells had positive gross and microscopic lesions 
on  the  10th  day after  transfer whether  the  bone marrow  was  derived from 
TABLE I 
Effect of the Immune Status and Number of Bone Marrow Cells on Adoptire Transfer 
of DH to BGG in Irradiated Recipients* 
Bone marrow  Lymph node cells,  1 X  10s 
donor status  donor  status 
Histologic evidence of DH to  BGG 
in 24-hr biopsies* 
nay  of  skin test after transfer 
4  5  I0 
Tolerant  Immune  +  (5.0)§  --  +  (2.5) 
Tolerant  --  --  -- 
Immune  Immune  +  --  + 
Tolerant  --  --  -- 
None  Immune (5 X 108) 
* Recipients given 550 R just before cell transfers; three animals included in each group. 
The results are expressed only as positive or negative for each group; responses within 
groups were uniform. 
§ The animals skin tested  on day 4 received 5 )<  108 bone marrow cells of the type in- 
dicated;  those tested on days 5 and 10 received 2.5  X  108 bone marrow cells. 
immune or  tolerant  animals.  Conversely,  if  tolerant  lymph  node  cells  and 
immune bone marrow cells were infused, no lesion developed.  The same  ex- 
periment was repeated with an increased number of bone marrow cells (5  X 
108). The results were similar except that the skin tests were now positive at 
4  days  (Table  I).  Thus  the  bone  marrow  from  immune animals played  a 
passive role  in  the  unstimulated recipients and  did  not  detectably enhance 
development of the DH lesion compared with marrow from tolerant animals. 
The necessity for the presence of bone marrow cells was evident from the lack 
of response in animals receiving only immune lymph node cells. 
lmmune bone  marrow  cells  alone  or  combinations of  bone  marrow  and 
thymus  cells,  from  normal,  tolerant,  or  immune donors,  were  infused  into 
recipients that  had  received  700  R  total  body irradiation. These  recipients 
2 Immune, normal, and tolerant cells mean cells removed from immune, normal, and toler- 
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were not stimulated by antigen in CFA and were skin tested on days 5, 8, and 
11  after  cell  infusion.  Occasional  weak  inflammatory  loci  were  seen  histo- 
logically (Table II), but in no group did more than two rats exhibit microscopic 
infiltrations of  mononuclear  cells. These  responses  were  not  considered posi- 
tive skin reactions to specific antigen but rather were compatible with a  small 
inflammatory response to the mechanical injury produced by injection. 
TABLE II 
Attempted  Adoptive  Transfer  of DH by Infusions of Bone Marrow or Thymus-Bone 
Marrow Combinations into Irradiated  (700 R) Rats 
Bone marrow, 
5  X  10s cells 
donor  status 
Immune 
Immune 
Immune 
Immune 
Normal 
Tolerant 
Thymus, 
2.5  X  19s cells 
donor  status 
Immune 
Normal 
Tolerant 
Immune 
Immune 
Histologic evidence of DH to BGG in 24 hr biopsy* 
Day 5 
0,  0,  0,  0,  0 
0,  0,  0,  0,  1+ 
0,  0,  0,  0,  0,  1+ 
0,  0,  0,  0,  0,  1+ 
O,  O,  O,  O,  1+ 
O,  O,  O,  O,  O,  1+ 
Day 8 
0,  0,  0,  1+,  1+ 
0,  0,  0,  0,  0 
0,  0,  0,  0,  1+,  1+ 
0,  0,  0,  0,  1+,  1+ 
0,  0,  0,  1+,  1+ 
O,  O,  O,  O,  O,  1+ 
Day 11 
0,  0,  0,  0,  0 
o,  o,  o,  o:~ 
o,  o,  l+,  o,  o,  1+ 
O,  O,  O,  O,  O,  1+ 
O,  O,  O,  O,  0 
O,  O,  O,  O,  0 
* Histologic findings  are given for  each  recipient and are graded on a 0-4+  basis,  al- 
though no reactions greater than l+  were found in this experiment. 
:~ One  animal died on day 9. 
TABLE  III 
Capacity of Bone Marrow Cells to Confer DH in Irradiated,  Antigen-Stimulated  Recipients* 
Bone marrow, 5  ;K 10s cells  Histologic evidence of DH to BGG in 2t-hr biopsies on day 8:~ 
Immune  2+,  2+,  2+,  2+,  2+,  3-+- 
Normal  0,  0,  0,  0,  0,  0,  1+,  1+ 
* Recipients were given 700 R just before cell transfer and CFA-BGG immediately after 
transfer. 
:~ Histologic findings are graded on a 0-4+ basis and results are given for each recipient. 
The  contribution  by  marrow  of  specifically reactive  cells was  further  ex- 
amined in recipients given 700 R  whole body irradiation and stimulated with 
CFA-BGG after cell infusions. Under these circumstances the group receiving 
normal bone marrow  cells alone responded weakly in  two  of eight recipients, 
while those receiving immune bone marrow cells produced moderate to strong 
responses in all six recipients at 8  days, as shown  in Table III. Thus,  in the 
presence  of  continued  antigenic  stimulation,  bone  marrow  from  immune 
animals was  capable  of  providing both  specifically sensitized  cells and  non- 
specific cells. 1148  THYMUS  AND  BONE  MARROW  IN  DELAYED  HYPERSENSITIVITY 
In this experiment two of eight recipients of normal bone marrow developed 
weak positive reactions on day 8. In other experiments  also,  there were some 
reactions  which might have  represented  "escape"  of the  irradiated  host,  i.e., 
partial recovery of bone marrow. The dose of irradiation was chosen to permit 
survival of recipients  of thymus cells alone; thus  the host's bone marrow was 
severely damaged but not completely eliminated.  This dose was also  too low 
to  destroy  all  host  lymphoid  tissue.  Control  animals  which  were  irradiated 
TABLE IV 
Devdopment of DH to BGG with Normal Thymus and~or Bone Marrow Cells in 
Irradiated, Antigen-Stlmulated Recipients* 
Irradiation dose 
Sources of cells (X  lOS)  Histologic  evidence of DHto BGGin 
24-hr biopsies$ 
Thymus  Bone marrow  Day 8  Day 11 
700 R  2.5  0  0,  0,  0,  0  0,  0,  0,  0 
0,  0,  0,  0  0,  0,  0§ 
0  5.0  0,  0,  0,  0  0,  0,  0,  0 
O,  O,  1+,  1+  O,  i+,  1+,  2+ 
2.5  5.0  1+,  1+,  2+  3+,  3+,  3+ 
2+,  2+,  3+  4+,  4+,  4+ 
850R  0  5.0  0,  0,  0  0,  0,  0 
0,  0,  1+  0,  0,  1+ 
2.5  5.0  O,  O,  O,  1+  O,  2+,  2+,  3+ 
* All recipients  given  irradiation  just  before cell transfer  and  CFA-BGG immediately 
after transfer. 
:~ Histologic findings are graded on a 0-4+ basis and results are given for each animal. 
§ One  recipient  died  on  day 9. 
and  stimulated  with  CFA-BBG but given no  cells  were included  in  each  ex- 
periment  (not shown in Tables).  These  animals  were uniformly unresponsive 
during the period of observation reported. 
Normal  bone  marrow  and  thymus  cells  were  used  alone  or  together  in 
irradiated  (700  R)  CFA-BGG-stimulated  recipients.  Neither  cell  type  alone 
was consistently  effective in producing a  lesion  at  day 8  or ll,  yet  the  com- 
bination  of  both  produced  lesions  at  these  times  (Table  IV).  When  normal 
bone  marrow  and  normal  thymus  cells  were  given  together  to  animals  re- 
ceiving  850  R  irradiation,  significant  lesions  were  first  evident  on  day  ll. 
When  normal  bone  marrow  alone  was  infused  into  recipients  of  850  R  ir- 
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animals were  considerably more  ill than  recipients  of  700  R  which  may  ac- 
count for the delay in appearance of positive lesions. 
Thymus  cells alone in an irradiated host would not be expected to produce 
an  early DH  lesion  since bone  marrow  cells are needed  to provide the  non- 
immunologic  component  that  is  also  essential.  To  evaluate  the  influence  of 
previous antigenic experience on thymus cells, we combined thymus cells with 
bone  marrow  from  tolerant  animals. Thymus  cells from  normal,  immune,  or 
tolerant  donors  were  injected into  irradiated  (700  R)  recipients followed by 
challenge with  CFA-BGG. As shown  in Table V,  immune  thymus  cells were 
more effective in the development of DH reactions and in initiating DH  at an 
TABLE V 
Effect of Immunologic Status of Thymus on the D~elopment of DH in Reconstituted, 
Irradiated, Antigen-Stimulated Recipients* 
Status of donors of thymus 
cells (2.5 X 10s cells) 
Histologic  evidence  of DH to BGG in 24-hr biopsies$ 
Day 8  Day 11 
Immune  1+,  1+,  1+,  2+,  2+  1+,  2+,  2+,  2+,  3+ 
3+,  3+,  3+  3+,  3+,  3+ 
Normal  0,  0,  0,  0,  1+,  1+,  1+  0,  0,  1+,  1+,  1+,  2+ 
1+,  1+  2+,  2+,  2+ 
Tolerant  0,  0,  0,  0,  0,  1+,  1+  0,  0,  1+,  1+,  1+,  1+ 
1+,  1+  1+,  2+,  2+ 
* All recipients received 700 R whole body irradiation, 5 X  l0  s bone marrow  cells from 
tolerant donors,  and were challenged  after cell transfer with CFA-BGG. 
:~ Histologic findings are graded on a 0-4+  basis and results are given for each animal. 
earlier time  than  normal  or  tolerant  thymus  cells.  No  differences were  seen 
between  groups  receiving  normal  or  tolerant  thymus  cells  combined  with 
tolerant bone marrow cells. 
DISCUSSION 
The results cited indicate that  cells from  the bone  marrow can  serve both 
actively as the source of specifically sensitized cells and passively as nonspecific 
responder cells. The nonimmunologic responder function  of the bone marrow 
cells was  shown  by  the  response  of  unstimulated  recipients  which  received 
immune lymph node cells and bone marrow from tolerant donors. In the absence 
of bone marrow cells no lesion was produced. The presence of either tolerant 
or immune  marrow  cells and immune lymph node cells allowed the lesion to 
develop and no difference in intensity or size of the lesion was evident between 
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testing was done immediately after cell transfer, but by increasing the number 
of bone marrow cells given we  could  decrease the  time interval between  cell 
transfer and development of a positive lesion. Thus a  critical number of bone 
marrow cells appeared to be necessary before a DH lesion could develop in the 
presence of sensitized  lymph node  cells  and  either  immune or  tolerant  bone 
marrow could provide those cells. 
Specifically  sensitized  cells  could,  however,  be  demonstrated  in  immune 
bone  marrow  by  continued  antigenic  stimulation.  In  irradiated  recipients 
stimulated  with  CFA-BGG,  bone  marrow  cells  alone  from  immune  donors 
produced significant DH skin lesions compared with those from bone marrow 
cells  of normal  donors.  The  marrow  of  immunized  animals  apparently  con- 
tained  specifically  sensitized  cells  which  under  the  influence  of  antigenic 
stimulation  could  initiate  the  DH  reaction.  This  does  not  imply  that  the 
sensitized  cells  either  originated  or were sensitized in  the  marrow;  they well 
might  have  migrated  to  marrow  after  sensitization  elsewhere.  Additional 
antigenic  stimulation  was  probably  required  to  expand  the  sensitized  cell 
population by cell division and/or recruitment. These results agreed with those 
of  Foerster  et  al.  (10),  who  found  bone  marrow  from  immune  "responder" 
guinea pigs effective in transferring responsiveness to nonresponder irradiated 
Hartley guinea  pigs which  were subsequently stimulated.  Also,  in  additional 
experiments, with normal F1 (Strain 2 X  13) marrow these investigators found 
a positive skin tests in only one of six Strain 13 guinea pigs that received marrow 
cells  alone,  whereas  with  F1  spleen  and  lymph node  cells plus  nonresponder 
Strain  13 marrow cells skin  tests were positive in  7 of 10 animals  (10).  Thus 
both rat and guinea pig immune marrow contain all of the elements needed for 
expression of DH,  although the evidence suggests that these cells are present 
in small numbers. This concept may explain the success of Bucklev et al. (11) 
who  transplanted  bone  marrow  to  a  patient  with  chronic  mucocutaneous 
candidiasis. While the possible effect of transfer factor was not ruled out, the 
delayed development of a  positive skin  test in  their patient was contrary to 
usual  transfer  factor  conversions  and  was  explicable  by  considering  that  a 
sensitized cell population expanded during continued antigenic stimulation. 
The  ability  of normal  bone  marrow  alone  to  provide  all  the  elements  for 
induction  of  DH  under  conditions  of  continued  antigenic  stimulation  was 
equivocal. Two of eight irradiated recipients (700 R) and one of six irradiated 
recipients (850 R) developed positive lesions following infusion of normal bone 
marrow  and  stimulation  by  CFA-BGG.  These  responses  may indicate  that 
normal  marrow  was  capable  of  complete  reconstitution,  or  may  reflect  a 
contribution  by  the  recipient  of  relatively  radioresistant  immunologically 
susceptible cells which  enabled DH to develop. An alternative explanation of 
these  results  is  that  normal marrow stem cells  repopulated  the  thymus  and 
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the time required for this to occur compared with the time required to develop 
DH  skin  lesions  in  our  animals  makes  this  explanation  unlikely.  While  the 
ability of normal bone marrow cells to provide trigger cells for DH was un- 
certain, a comparison of Tables III and IV indicated that during the induction 
of DH in an irradiated  stimulated  recipient  the marrow played more than  a 
passive role.  Normal thymus  cells  combined with  normal bone marrow cells 
gave more vigorous responses in a greater proportion of animals than did normal 
thvmus cells and tolerant bone marrow ceils. 
In conclusion, the function of bone marrow cells in DH can be summarized on 
two  operational  levels.  Firstly,  in  immune  animals  the  bone  marrow  does 
contain  trigger  cells which  can be readily  demonstrated  under  conditions  of 
continued antigenic stimulation. Secondly, in the presence of sensitized lympho- 
cytes DH lesions  are expressed only in  the presence of bone marrow and  at 
this  level  of  DH  responsiveness  the  bone  marrow  acts  in  a  passive nonim- 
munologic role. 
The role of cell cooperation in the development of DH was explored by using 
irradiated  stimulated  recipients which  received thymus  and/or  bone marrow 
cells  from normal  donors.  Animals  receiving  both  cell  types  developed  sig- 
nificant lesions on  days 8  and  11,  whereas rats infused  with  either  cell type 
alone did not produce skin reactions. This evidence for bone marrow-thymus 
cell cooperation during the induction of DH is in accord with the observations 
of Claman et al. (13)  and Miller and Mitchell (14)  on the induction of antibody 
response to certain  antigens.  Similarly, in  the  area of cellular immunity,  co- 
operation between cells from these two sources has been described for the in- 
duction  of  contact  sensitivity  in  mice  (15),  the  mouse  footpad  response  to 
methylated human serum albumin (16), the homograft reaction (17), and both 
in vivo (18)  and in vitro (19)  graft versus  host reactions. Our findings provide 
further  evidence that  bone marrow-thymus cell  cooperation  is  important,  if 
not essential, during induction of cellular immunity. Our experiments, however, 
in addition to those cited, required the presence of marrow cells to express the 
lesion and  therefore from these experiments it was not possible to determine 
whether  thymus  cells  alone in  an irradiated,  antigen-stimulated  host  might 
have produced  "trigger"  cells.  It  was  clear  that  trigger  cells  were  not  con- 
sistently produced in the absence of thymus cells. 
Our last set of experiments demonstrated that, when combined with tolerant 
bone marrow, cells found within the thymuses of immune animals were capable 
of producing a DH lesion in an irradiated, antigen-stimulated recipient, whereas 
those  within  the  thymuses  of  normal  or  tolerant  donors  did  not,  or  did  so 
weakly.  Thus,  the  evidence  presented  here  indicated  the  ability  of  normal 
thymus  cells  to  permit  the  recipient  to  develop DH  and  demonstrated  the 
presence of immunocompetent cells in the thymus glands of immune animals. 
These  results  were  in  accord  with  those  of  Asherson  and  Ptak,  who  found 1152  THYMUS  AND  BONE  MARROW  IN  DELAYED  HYPERSENSITIVITY 
that  normal  thymus  and  bone  marrow  cells  could  partially  restore  contact 
sensitivity  to mice rendered  tolerant  to picryl chloride and irradiated before 
cell  transfer  (20).  They also reported  that  such  restoration  could  not  be ac- 
complished  in  nonirradiated  recipients.  The  recent  report  by Takada  et  al. 
provided evidence that survival of donor cells was better in irradiated  hosts 
than in normal hosts and  thus  the irradiated  recipient may be a  much  more 
sensitive animal to demonstrate donor cell function (21). The failure to trans- 
fer DH with immune thymus cells in normal guinea pigs (22)  and the failure 
to  restore  DH  in  neonatally  thymectomized rats  with  normal  thymus  (23) 
might have been because of poor survival of donor cells in a normal recipient. 
In addition, we have antigenically challenged our recipients to expand a small 
sensitized cell population and have based our results on histologic characteris- 
tics which permitted a more precise evaluation of the nature  of a  small lesion 
than  does  gross  measurement.  Whether  the  thymus  cells  in  immune  donors 
acquired  their  specific  responsiveness  within  the  thymus,  or  whether  cells 
sensitized elsewhere migrate (back) to the thymus, was  not established by our 
experiments.  Under  appropriate circumstances thymus cells from an immune 
animal could be shown,  however,  to contain  specifically sensitized  cells or at 
least cells committed to a particular antigen. 
SUMMARY 
Adoptive transfer experiments were performed to define  the immunological 
role of thymus and bone  marrow cells in the induction  of delayed hypersensi- 
tivity (DH). The results indicated the following. (a) Bone marrow from immune 
donors contained  cells capable of being  stimulated  by antigen  to initiate  the 
expression of DH.  (b)  Bone marrow from nonimmune or tolerant donors  con- 
tained cells that were needed  to complete the expression of DH after the in- 
fusion of immune lymph node cells.  (c) Normal bone marrow and thymus  cells 
cooperated  in  the  irradiated  recipient  to  induce  the  most  vigorous skin  re- 
actions to specific antigen;  these reactions were seen only when the recipients 
were stimulated by antigen.  Either cell type alone was ineffective. (d)  In  the 
presence  of  tolerant  bone  marrow  cells,  thymus  cells  from immune  donors 
gave a more vigorous response than did thymus cells from normal or tolerant 
donors. (e) There was suggestive evidence that thymus cells were the source  of 
trigger elements that initiated DH. (f) Antigen in the irradiated recipient was 
necessary to  induce  DH  after infusion  of  bone  marrow  cells  alone,  or  bone 
marrow and thymus cells together. 
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